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Abstract
Introduction: We report the case of a 58-year-old Caucasian Greek man who presented with dry cough, fever,
bilateral alveolar infiltrates and acute hepatitis.
Case presentation: After a lung biopsy, the patient was diagnosed with Wegener’s granulomatosis. The diagnosis
was supported by the presence of anti-proteinase-3 anti-neutrophil cytoplasmic antibodies. A liver biopsy
demonstrated the presence of mild non-specific lobular hepatitis and periodic acid-Schiff positive Lafora-like
inclusions in a large number of his liver cells. The patient was treated with prednisone and cyclophosphamide,
which was followed by subsequent remissions of chest X-ray findings and liver function studies.
Conclusion: What makes this case worth reporting is the coexistence of liver inflammation with a biochemical
profile of severe anicteric non-viral, non-drug induced hepatitis coinciding with the diagnosis of Wegener’s
granulomatosis. Our paper may be the first report of hepatic involvement in a patient diagnosed with Wegener’s
granulomatosis. The aetiological link between the two diseases is supported by the reversion of hepatitis after the
immunosuppression of Wegener’s granulomatosis. We favor the hypothesis that hepatic vasculitis may be the
cause of acute hepatocellular necrosis.
Introduction
Wegener’s granulomatosis is an anti-neutrophil cyto-
plasmic autoantibody (ANCA)-associated small vessel
systemic vasculitis characterized primarily by necrotizing
granulomatosis of the upper and lower respiratory tract
and by glomerulonephritis. We report the case of a 58-
year-old man with symptoms of Wegener’sg r a n u l o m a -
tosis who developed acute anicteric hepatitis.
Case presentation
A 58-year-old Caucasian man of Greek origin and
nationality was transferred to our hospital’sI n t e r n a l
Medicine Department due to a marked elevation of his
hepatic enzymes. He had a long history of rhinitis con-
sidered to be of allergic origin and with an epidermal
sensitivity test that was positive to parietaria species. He
had no history of alcohol abuse.
Nine months before he was admitted to our hospital,
he developed an acute hearing loss in his right ear (trea-
ted without improvement with dimenhydrinate and
pyridoxine by his otolaryngologist), which was followed
shortly after by a worsening dry cough. Eight weeks
before our evaluation, he reported fatigue, loss of appe-
tite and weight loss of about 4 kg to 5 kg. In the last
three weeks of that same period, his temperature rose to
38.8°C and he was treated without improvement with
oral antibiotics (cefprozil and clarithromycin) by his
local physician. Due to the persistence of his fever, after
being treated with antibiotics for seven days he was
referred by his local physician to the pneumonology
department of our hospital. At that time, he was afeb-
rile. Chest radiography revealed the presence of bilateral
alveolar infiltrates, while liver function tests were within
normal range. Bronchoscopy was negative for structural
abnormalities, and culture of bronchoalveolar lavage
fluid was negative. A chest computed tomography (CT)
scan was performed in which the presence of multiple
lung masses (nodular opacities) was noted. The result of
a Mantoux skin test was negative and a complete immu-
nologic serologic profile was pending when the patient
was transferred to our department because of the eleva-
tion of his hepatic enzymes, starting a week after his
admission.
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rate was 68 beats/min, respiratory rate was 16 breaths/
min, and blood pressure was 140/70 mmHg. His lungs
were clear to auscultation bilaterally. His abdomen was
neither tender nor distended, and his liver was palpable
4 cm below the costal margin. The findings on the rest
of the examination procedures were normal, as was his
echocardiogram. Laboratory investigation showed the
following data: white blood cell count, 10.7 × 10
9/L
(with 66% neutrophils); hemoglobin, 11.4 g/dL; mean
cell volume, 93.9fl; platelet count, 437 × 10
9/L; erythro-
cyte sedimentation rate, 92 mm/1 h; C-reactive protein,
8.8 mg/dl; creatinine, 0.9 mg/dL; serum urea nitrogen,
34 mg/dL; aspartate aminotransferase, 781 U/L; alanine
aminotransferase, 512 U/L; alkaline phosphatase, 322 U/
L; albumin, 3.1 g/dL; a1-antitrypsin, 184 mg/dL; IgG,
1980 mg/dl; IgA, 413 mg/dl; and IgM, 55.6 mg/dl. A
urine analysis was negative for glycosuria and protei-
nuria, while urine microscopy revealed 3 to 5 red blood
cells per high power field and the presence of occasional
dysmorphic red blood cells.
The tests for hepatitis B, hepatitis C, hepatitis A and
human immunodeficiency viruses all returned negative
results. The results from the immunologic assays
denoted the presence of ANCA against proteinase 3,
which was confirmed by both immunofluorescence
assay and Elisa anti-proteinase 3 antibodies. At the same
time, tests for antinuclear antibodies, anti-smooth mus-
cle antibodies and anti-liver kidney microsomal antibo-
dies were all negative. An upper abdomen CT scan also
yielded normal results.
A biopsy of our patient’s nasal mucosa did not reveal
any changes that were compatible with necrotizing vascu-
litis. A complete ophthalmologic examination was also
performed and was negative for ocular abnormalities. Our
patient’s liver function tests kept worsening and his transa-
minase levels reached a 15-fold increase within a week fol-
lowing admission. However, his bilirubin remained within
normal values (1.2 mg/dl). A fine needle biopsy of his pul-
monary lesions was obtained and the histological findings
were compatible with Wegener’s granulomatosis. The
characteristic pathological features were irregular areas of
necrosis surrounded by inflammatory granulation tissue
(Figure 1) and neutrophilic microabscesses were sur-
rounded by a granulomatous reaction with an occasional
multinucleate Langhan’s giant cell (Figure 2). A liver
biopsy was also performed, and histological evaluation
revealed mild non-specific lobular hepatitis characterized
by randomly distributed focal hepatocellular necrosis with
collections of neutrophils and lymphocytes. A few apopto-
tic cells and moderate sinusoidal reaction were also
observed. A large number of liver cells exhibited periodic
acid Schiff-positive Lafora-like inclusions. Occasional por-
tal tracts showed mild leucocytic infiltrations (Figure 3).
Our patient later received a combined treatment of 1
mg/kg/day prednisone and 2 mg/kg/day of cyclopho-
sphamide. Our patient’s status gradually improved with
a remission of both the chest X-ray findings and the
liver function studies 25 days after the initiation of treat-
ment (Figure 4). After all signs of active disease had dis-
appeared, a gradual tapering of corticosteroid and
cyclophosphamide therapy was initiated. Eighteen
months after his hospitalization, the patient is free of
symptoms, with normal results for liver function tests
and without any sign of relapse.
Discussion
Our patient had a long history of rhinitis that may
represent a slowly progressive mild Wegener’sg r a n u l o -
matosis. The main onset of symptoms was the acute
Figure 1 Lung biopsy (fine needle biopsy), periodic acid Schiff
stain ×400 magnification.
Figure 2 Lung biopsy (fine needle biopsy), hematoxylin and
eosin stain ×400 magnification.
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10% of patients at the time of their presentation and in
40% overall during the course of their illness. The diag-
nosis of Wegener’sg r a n u l o m a t o s i sw a sb a s e do nt h e
clinical manifestations, imaging studies, and pathogno-
monic tissue abnormalities from our patient’sl u n g
biopsy. The diagnosis was further supported by the pre-
sence of c-ANCAs, mild leukocytosis and normocytic
normochromic anemia in our patient.
What was surprising, however, and what makes this
case worth reporting, was the coexistence of liver
inflammation with a biochemical profile of severe anic-
t e r i ch e p a t i t i sa tt h et i m eo fW e g e n e r ’s granulomatosis
diagnosis. Drug-induced liver damage was highly unli-
kely because liver dysfunction and the elevation of hepa-
tic enzymes persisted after the discontinuation of
antibiotics. A viral hepatitis was ruled out considering
that serologies for acute HBV, HAV and HCV infections
were repeatedly negative when checked at different
times, that the possibility of ischemic hepatitis in a
patient without previous heart condition history was nil,
and that our patient had hemodynamic stability and a
perfectly normal echocardiogram.
Autoimmune hepatitis (AIH) cannot be ruled out as
well, since 10% of these cases may present with negative
antinuclear antibodies, anti-smooth muscle antibodies,
and anti-liver kidney microsomal antibodies. According
to the revised criteria and scoring system by the Inter-
national AIH Group [1], our patient’s AIH score was 11
+, a fact that initially made this diagnosis probable.
Furthermore, ANCAs are positive in 65% to 95% of
patients with AIH. However, they are usually of the
perinuclear type and the histological findings from the
liver biopsy in our patient were non-specific.
In patients with systemic vasculitis syndromes, clinical
manifestations in the liver are not frequent, although a
case series notes that liver arteritis is not an infrequent
finding, especially in patients with polyarteritis nodosa
[2-4] or systemic lupus erythematosus [5]. The most
common hepatic complications in patients with polyar-
teritis nodosa as reported in the literature [3,4] are
hepatic infarction or aneurysm rapture, acute liver fail-
ure [6], ischemic cholangitis [7], and nodular regenera-
tive hyperplasia [7,8]. Necrotizing arteritis of the liver
was found in between 10% and 21% of patients with sys-
temic lupus erythematosus in an autopsy series [5].
However, these findings are not related to hepatic clini-
cal manifestations. In Wegener’s granulomatosis,
Figure 3 (A) Liver biopsy showing focal necrosis with
neutrophils and sinusoidal reaction, hematoxylin and eosin
stain ×400 magnification [R1]. (B) Liver biopsy showing Lafora
body-like inclusions, hematoxylin and eosin stain ×400
magnification [R2].
Figure 4 Liver function tests in the course of time (0 on the X
axis stands for the first day of admission to our department).
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litis, granulomas or both, gastrointestinal involvement is
very uncommon and the liver is extremely rarely
affected [9]. Only isolated cases associated with primary
biliary cirrhosis and hepatic granulomas are reported.
Shah et al. [10], reported a case of Wegener’sg r a n u l o -
matosis with perivascular and periportal granuloma with
Langhan’s giant cells. Boissy et al. [11] reported a case
of Wegener’s granulomatosis in which portal inflamma-
tory granuloma and vasculitis with portal tract fibrosis
and venous lesions were found. Zen et al. [12] reported
a case of incomplete septal cirrhosis associated with
Wegener’s granulomatosis and Sjögern’s syndrome. A
very rare form of hepatotoxicity was reported only twice
in the literature [13,14].
Cyclophosphamide-induced noncaseating granuloma-
tous hepatitis in Wegener’s granulomatosis was also
ruled out from the start in this case, because hepatitis
was apparent well before the initiation of Wegener’s
granulomatosis treatment with cyclophosphamide. In
our case, neither vasculitis of the portal tracts nor gran-
ulomas that would have revealed a possible necrotizing
angiitis (Wegener’s granulomatosis type) of the liver was
detected. Nevertheless, this possibility cannot be
excluded, since only seven portal tracts were examined.
The histological findings of mild hepatic necrosis in aci-
nar zones 3 and 2 with concomitant mild inflammation
of predominantly neutrophils and mononuclear cells
with portal tracts and the nearly normal periportal par-
enchyma are compatible with vascular damage resulting
in the hypoperfusion of the liver. This hypothesis is
reinforced by the immediate response of liver function
tests after immunosuppressive therapy with prednisone
and cyclophosphamide was initiated.
The histological finding of ground-glass inclusions
within hepatocytes is common in HBV infection and has
also been reported in drug-induced liver damage (cyana-
mide, disulfiram), Lafora’s disease (myoclonus epilepsy),
type IV glycogenosis, fibrinogen storage disease, and
acute veno-occlusive disease [15]. There have also been
several reports of immunosuppressed patients on
numerous medications with ground-glass hepatocellular
inclusions [16]. Our patient had normal serum levels of
a1-antithrypsin, was HBV seronegative, had no history
of drug abuse, and did not demonstrate clinical findings
of myoclonus epilepsy or seizures under a normal elec-
troencephalogram test.
Recently, Lefkowitch et al. [17] suggested that ground-
glass inclusions within hepatocytes are the result of dis-
turbed glycogen metabolism. Whether this cytoplasmic
change in our patient was an incidental finding due to
his disturbed glycogen metabolism or was related to the
liver involvement of Wegener’s granulomatosis cannot
be ascertained. In this case, liver biopsy showed non-
specific hepatitis with mild lobular activity. The absence
of histological findings compatible with Wegener’s gran-
ulomatosis could be attributed to sampling, since liver
damage in Wegener’s granulomatosis is expected to be
focal and not diffused.
Conclusion
To the best of our knowledge, this report presents one
of the first cases of hepatic involvement in a Wegener’s
granulomatosis patient. The aetiological link between
the two diseases is supported by the reversion of hepati-
tis after the immunosuppression of Wegener’sg r a n u l o -
matosis, and we favor the hypothesis that hepatic
vasculitis may be the cause of acute hepatocellular
necrosis. The simultaneous finding of Lafora body-like
inclusions in our patient’s hepatocytes makes the case
even more intriguing, even when an incidental coinci-
dence cannot be ruled out.
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